India's Serum applies to conduct local trial for Novavax vaccine: CEO

The Serum Institute of India (SII), the world's biggest vaccine maker, has applied to local authorities to conduct a small domestic trial of Novavax Inc's COVID-19 vaccine, which was found to be 89.3% effective in a UK trial.

from bdnews24.com - Home https://ift.tt/3ahp93t